Clinical Trials on Continuous Methamphetamine Dependence in New Zealand

Total 337 results

National Institute on Drug Abuse (NIDA)

Completed

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

Methamphetamine Dependence

United States
NYU Langone Health
Forest Laboratories

Completed

A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction (AcampMet)

Methamphetamine Dependence, Treatment Seeking

United States
Catalyst Pharmaceuticals, Inc.

Terminated

Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence

Methamphetamine Dependence

United States
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR)

Recruiting

Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

Addiction | Methamphetamine-dependence | Addiction, Substance | Methamphetamine Abuse

Canada
Juul Labs, Inc.

Completed

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Juul Labs, Inc.

Completed

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Affect Therapeutics, Inc.

Completed

Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder

Methamphetamine Abuse

United States
Affect Therapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

Methamphetamine Abuse

United States
University of New Mexico
University of Iowa; University of Utah

Withdrawn

A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders

Methamphetamine Abuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder (ADAPT-2)

Methamphetamine Use Disorder

United States
New York State Psychiatric Institute

Terminated

Gabapentin Treatment of Benzodiazepine Dependence

Benzodiazepine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Chronic Pain and Opioid Dependence Assessment and Treatment (CPODAT)

Chronic Pain | Opioid Dependency

United States
New York State Psychiatric Institute

Completed

Pharmacogenetics of Naltrexone for Stimulant Abuse

Substance Use Disorders | Methamphetamine Abuse

United States
University of Chicago

Completed

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life (Ramp-it-Up)

Continous Flow Left Ventricular Device

United States
InterveXion Therapeutics, LLC
National Institute on Drug Abuse (NIDA)

Terminated

Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose (Meth-OD)

Methamphetamine Intoxication (Disorder)

United States
National Cancer Institute (NCI)
Celgene Corporation

Active, not recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Developing a Smoking Cessation Intervention for Methadone Maintained Smokers

Nicotine Dependence | Opiate Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Combined Pharmacotherapy for Cannabis Dependency (D-LUCS)

Cannabis Dependence | Marijuana Dependence

United States
Catalyst Pharmaceuticals, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Study of CPP-115

Cocaine Dependency

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Freedom Laser, Inc.
NST Consultants, Inc.

Completed

Evaluation of LLLT/Music for Smoking Cessation

Nicotine Dependence, Cigarettes

United States
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Nalrexone Facilitated Discontinuation of Buprenorphine

Stable Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Substance-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Opiate Dependence

United States
Yale University

Completed

Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1

Nicotine Dependence, Other Tobacco Product

United States
State University of New York - Upstate Medical...
US Department of Veterans Affairs

Terminated

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

Alcohol Dependence | Veterans

United States
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
Yale University

Withdrawn

Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).

Drug Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Omeros Corporation

Terminated

Pioglitazone for Heroin and for Nicotine Dependence

Heroin Dependence | Nicotine Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

A Placebo-Controlled Trial of Memantine for Alcohol Dependence

Alcohol Abuse | Alcohol Dependence (Primary Condition)

United States
GlaxoSmithKline

Withdrawn

Relapse Prevention Study in Newly Abstinent Smokers

Substance Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

Benzodiazepine Dependence | Opioid Dependence

United States
Albany College of Pharmacy and Health Sciences
Merck Sharp & Dohme LLC

Completed

Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis

End Stage Renal Disease | Continuous Ambulatory Peritoneal Dialysis

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Exercise as a Treatment for Substance Use Disorders Protocol (STRIDE)

Stimulant Abuse and Dependence

United States
Yale University

Completed

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

Cocaine Dependence | Opiate Dependence

United States
Yale University
National Cancer Institute (NCI)

Completed

Alcohol Counseling for Telephone Quitline Callers

Smoking | Alcohol Dependence | Nicotine Dependence

United States
Rowan University
University of Kentucky

Recruiting

Re-Connect Application for Smoking Cessation

Smoking Cessation | Nicotine Dependence, Cigarettes | Acceptability of Health Care

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health...

Completed

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

Transgender, HIV Continuum of Care

United States
Roswell Park Cancer Institute
National Comprehensive Cancer Network

Completed

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Stage I Mantle Cell Lymphoma | Stage II Contiguous Mantle Cell Lymphoma | Stage II Non-Contiguous Mantle Cell Lymphoma

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

FMRI of Stress and Addictive Disorders

Alcoholism | Opioid Dependence | Cocaine Dependence | Adolescents | Pathological Gamblers

United States
New York State Psychiatric Institute

Terminated

Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment

Smoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Nicotine Dependence | Cigarette Smoking | Tobacco Dependence | Nicotine Use Disorder | Smoking, Cigarette

United States
Click Therapeutics, Inc.

Completed

Clinical Trial of Smoking Cessation Mobile Phone Program

Substance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine Addiction

United States

Clinical Trials on Continuous Methamphetamine Dependence in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations